首页 | 本学科首页   官方微博 | 高级检索  
     


Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial
Authors:Q.P. Janssen  M.G. Besselink  M.Y.V. Homs  G. van Tienhoven  J.W. Wilmink  B. Groot Koerkamp
Affiliation:1. Surgery, Erasmus University Medical Center, Netherlands;2. Surgery, Amsterdam UMC, University of Amsterdam, Netherlands;3. Medical Oncology, Erasmus University Medical Center, Netherlands;4. Radiotherapy, Amsterdam UMC, University of Amsterdam, Netherlands;5. Medical Oncology, Amsterdam UMC, University of Amsterdam, Netherlands
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号